ArcherDX Reports on Detecting Meaningful Mutations From Liquid Biopsies in New Webinar

Share Article

LabRoots will host the webinar January 19, where attendees will learn of the Archer® Reveal ctDNA™ 28 kit, and its ability to produce powerful, accurate and fast mutation analysis from liquid biopsies.

Liquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational status. Cell free DNA (cfDNA) can be profiled from liquid biopsy samples, although the abundance is generally low, ranging from less than 1ng to 30ng cfDNA per mL blood in healthy individuals. This ctDNA is typically highly fragmented, and thus NGS-based methods to detect oncogenic driver mutations from liquid biopsies must be sensitive enough to detect low-frequency mutations from low inputs of highly fragmented material.

Anchored Multiplex PCR (AMP™) is proprietary target enrichment chemistry for NGS that is uniquely suited for highly fragmented material such as FFPE-derived nucleic acids and liquid biopsy-derived ctDNA. In this free webinar, members of the ArcherDX team will describe AMP-based ctDNA library preparation, highlighting the use and advantages of molecular barcoded adapters to unambiguously remove PCR duplicates, correct for PCR or sequencer-derived sequence errors, and flag run-to-run contamination.

Participants of the webinar can expect to gain a better understanding of both the value of mutation analysis from ctDNA in liquid biopsies and the challenges of analyzing ctDNA by next-generation sequencing. Viewers will learn how the Archer Reveal ctDNA 28 kit uses Anchored Multiplex PCR target enrichment chemistry to detect and characterize ctDNA.

LabRoots will host the webinar free for users on January 19, 2017, beginning at 8 a.m. PT, 11 a.m. ET. For more on this event, P.A.C.E and Florida continuing education credits, or to register for free, click here.

About ArcherDX
ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications.

By combining proprietary AMP chemistry and easy-to-use, lyophilized reagents, Archer NGS assays generate highly enriched sequencing libraries to detect gene fusions, point mutations, CNVs and RNA abundance. Complemented by the Archer suite of bioinformatics software, ArcherDX technology dramatically enhances complex mutation identification and discovery.

ArcherDX is headquartered in Boulder, Colorado.
Archer®, Reveal ctDNA™ and AMP™ are trademarks of ArcherDX, Inc.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website